Biotronik says the FDA approved its ultra-high-energy implantable cardioverter defibrillator, the Inventra DX, plus the Itrevia DX line for complex cases.
Biotronik said last week that the FDA approved 2 of its implantable cardioverter defibrillators designed to deliver an ultra-high-energy initial shock.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1G0X3kH
Cap comentari:
Publica un comentari a l'entrada